To eliminate cervical cancer in Canada, nationwide funding of self-sampling for human papillomavirus is needed.

The article discusses the need for nationwide funding of self-sampling for human papillomavirus (HPV) in order to eliminate cervical cancer in Canada. The research shows that increasing self-sampling uptake among underscreened populations would have the greatest impact in preventing cervical cancer. Cervical cancer disproportionately affects young people and equity-seeking populations, who are also the least likely to be screened. The article emphasizes that HPV vaccination alone will not eradicate cervical cancer and highlights the benefits of self-sampling, including increased privacy, convenience, and reach among underscreened individuals. The evidence shows that self-collected samples are as sensitive as physician-collected samples, and self-sampling is cost-effective compared to traditional methods. The article concludes by urging all health systems in Canada to fund self-sampling in order to eliminate cervical cancer. [Extracted from the article]